Objectives. To review the rationale and development of a multidiscipli
nary amiodarone clinic, and document the clinical outcomes resulting f
rom its implementation. Methods. A clinic was established to provide a
n ambulatory setting in which patients receiving amiodarone could be f
ollowed according to published guidelines by a multidisciplinary team
of cardiovascular health care specialists. Patients receiving amiodaro
ne were referred to the clinic by their primary physicians. A data bas
e containing each patient's medical history, current drug therapy, and
baseline laboratory values was developed during the initial visit. Li
ver function tests, thyroid function tests, and chest radiographs were
performed every 6 months, and pulmonary function tests were scheduled
on an annual basis. Dosage adjustments were performed in select patie
nts. Results. Since November 1996, 60 patients have been referred to t
he amiodarone clinic. Mean length of follow-up before and after referr
al was 16.3 +/- 25.5 and 9.2 +/- 5.5 months, respectively. Laboratory
tests were performed according to accepted guidelines in 14 (23%) pati
ents before referral compared with 54 (90%) patients after enrollment
(p<0.001). Previously unrecognized adverse events were detected in 21
(35%) patients, including pulmonary fibrosis, QT prolongation, liver e
nzyme elevation, hypothyroidism, hygerthyroidism, and asthma exacerbat
ion Amiodarone was discontinued in six patients, four of whom had susp
ected pulmonary toxicity. The dose of amiodarone was adjusted in 29 (4
8.4%) patients. Conclusion. Many patients receiving amiodarone are not
being followed according to published recommendations, Implementation
of a specialized, multidisciplinary amiodarone clinic improves outcom
es by monitoring for early detection of drug-related toxicities and by
facilitating proper dosage modifications.